Natural product-based therapy for T2DM: Thermostable extract of fenugreek seeds (TEFS) enhances insulin secretion by increasing glucagon-like peptide-1 secretion via up regulation of its target gene, 13/May/2015, 23.22

Small molecule-based therapy for p53-deficient tumors: IAPP (Amylin) increases the expression of tumor suppressor PTEN and induces regression of p53-mutated human tumors via up regulation of its target gene, 13/May/2015, 23.17
May 13, 2015
Natural product-based Immune augmentation therapy: (6)-Gingerol, a pungent component of Ginger, promotes NK cell maturation and function via up regulation of its target gene, 14/May/2014, 9.01 am
May 14, 2015
Show all

A study from the Clinic for Endocrinology, Diabetes & Metabolism and Department Biomedicine, University Hospital Basel, Basel, Switzerland shows that Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.” This study was published in the 30 October  2011 issue of the journal “Nature Medicine” [the number 1 journal in General Medicine with an I.F of 24.973] by Prof. Donath MYEllingsgaard H and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for T2DM: Thermostable extract of fenugreek seeds (TEFS) enhances insulin secretion by increasing glucagon-like peptide-1 secretion via up regulation of its target gene. 

Significance:

 Given that (1)  more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) the life-long painful injection/drug treatment is required to treat DM; and (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find a way to induce regeneration of adult β-cells that were lost in DM.

This study suggests, for the first time, that Thermostable extract of fenugreek seeds (TEFS), by increasing the expression of its target gene, it may increase glucagon-like peptide-1 secretion.  Thereby, it may increase (1) insulin secretion from L cells and alpha cells;  and (2) induce regeneration of insulin-secreting cellsThus, pharmacological formulations encompassing Thermostable extract of fenugreek seeds (TEFS) or small molecule compounds isolated from it may be used to treat T2DM. 

Undisclosed information: How Thermostable extract of fenugreek seeds (TEFS) increases glucagon-like peptide-1 and insulin secretion.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Natural product-based therapy for T2DM: Thermostable extract of fenugreek seeds (TEFS) enhances insulin secretion by increasing glucagon-like peptide-1 secretion via up regulation of its target gene, 13/May/2015, 23.22,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.